Journal of International Oncology ›› 2013, Vol. 40 ›› Issue (2): 83-85.

    Next Articles

Research progress of FLIP in cancer

SHEN  Jue, LI  Yu-Feng, HE  Zhen-Juan   

  1. Department of Pediatrics, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
  • Online:2013-02-08 Published:2013-01-25
  • Contact: Corresponding author: LI Yu-feng, E-mail: mieuniversity@hotmail.com E-mail:mieuniversity@hotmail.com

Abstract: FLIP is a protein containing death domain. Human beings have three subtypes of c-FLIPL, c-FLIPS and c-FLIPR, which can inhibit the apoptosis of a variety of tumor cells. C-FLIPL plays a dual role in the apoptotic signal. The expression level of FLIP not only decides the opening and closing of the apoptosis pathway but also achieve the conversion of cells in the apoptotic signaling and proliferative signaling pathway. The regulation of FLIP’s expression is a multi-layered, involving multiple signaling pathways. FLIP will probably become an attractive death receptor signaling target of therapy.

Key words: FLIP, Apoptosis, Signaling pathway, Regulation